205 related articles for article (PubMed ID: 8370634)
21. Effects of salmon calcitonin suppositories on bone mass and turnover in established osteoporosis.
Kollerup G; Hermann AP; Brixen K; Lindblad BE; Mosekilde L; Sørensen OH
Calcif Tissue Int; 1994 Jan; 54(1):12-5. PubMed ID: 8118746
[TBL] [Abstract][Full Text] [Related]
22. [Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].
Campusano C; López JM; Campino C; Cárdenas I; Rojas A
Rev Med Chil; 2000 Apr; 128(4):387-91. PubMed ID: 10962855
[TBL] [Abstract][Full Text] [Related]
23. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
24. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
[TBL] [Abstract][Full Text] [Related]
25. A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium.
Reginster JY; Meurmans L; Deroisy R; Jupsin I; Biquet I; Albert A; Franchimont P
Eur J Clin Invest; 1994 Aug; 24(8):565-9. PubMed ID: 7982445
[TBL] [Abstract][Full Text] [Related]
26. An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss.
Gennari C; Agnusdei D; Montagnani M; Gonnelli S; Civitelli R
Calcif Tissue Int; 1992 Apr; 50(4):381-3. PubMed ID: 1571851
[TBL] [Abstract][Full Text] [Related]
27. Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.
Overgaard K; Hansen MA; Dirksen KL; Christiansen C
Calcif Tissue Int; 1992 Sep; 51(3):184-8. PubMed ID: 1422962
[TBL] [Abstract][Full Text] [Related]
28. Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis.
Thamsborg G; Jensen JE; Kollerup G; Hauge EM; Melsen F; Sorensen OH
Bone; 1996 Feb; 18(2):207-12. PubMed ID: 8833216
[TBL] [Abstract][Full Text] [Related]
29. Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study.
Ljunghall S; Gärdsell P; Johnell O; Larsson K; Lindh E; Obrant K; Sernbo I
Calcif Tissue Int; 1991 Jul; 49(1):17-9. PubMed ID: 1893291
[TBL] [Abstract][Full Text] [Related]
30. A double blind study of intranasal calcitonin for established postmenopausal osteoporosis.
Kapetanos G; Symeonides PP; Dimitriou C; Karakatsanis K; Potoupnis M
Acta Orthop Scand Suppl; 1997 Oct; 275():108-11. PubMed ID: 9385282
[TBL] [Abstract][Full Text] [Related]
31. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.
Adachi JD; Bensen WG; Bell MJ; Bianchi FA; Cividino AA; Craig GL; Sturtridge WC; Sebaldt RJ; Steele M; Gordon M; Themeles E; Tugwell P; Roberts R; Gent M
Br J Rheumatol; 1997 Feb; 36(2):255-9. PubMed ID: 9133941
[TBL] [Abstract][Full Text] [Related]
32. [Calcitonin nasal spray for Paget's disease of the bone].
Luboshitzky R; Bar-Shalom R
Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study.
Gonnelli S; Cepollaro C; Pondrelli C; Martini S; Rossi S; Gennari C
Osteoporos Int; 1996; 6(4):303-7. PubMed ID: 8883119
[TBL] [Abstract][Full Text] [Related]
34. Use of nasally administered salmon calcitonin in preventing bone loss.
Christiansen C
Calcif Tissue Int; 1991; 49 Suppl 2():S14-5. PubMed ID: 1933614
[TBL] [Abstract][Full Text] [Related]
35. Salmon calcitonin in the prevention of bone loss at perimenopause.
Arnala I; Saastamoinen J; Alhava EM
Bone; 1996 Jun; 18(6):629-32. PubMed ID: 8806006
[TBL] [Abstract][Full Text] [Related]
36. The effect of intranasal salmon calcitonin on biochemical parameters of bone turnover in postmenopausal women.
Balint-Perić LA; Prelević GM; Beslagić Z; Petrović J
Gynecol Endocrinol; 1994 Dec; 8(4):241-5. PubMed ID: 7709763
[TBL] [Abstract][Full Text] [Related]
37. Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
Resch H; Pietschmann P; Willvonseder R
Calcif Tissue Int; 1989 Oct; 45(4):209-13. PubMed ID: 2509007
[TBL] [Abstract][Full Text] [Related]
38. [Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes].
Overgaard K; Ravn P; Hansen MA; Christiansen C
Ugeskr Laeger; 1993 Aug; 155(31):2387-91. PubMed ID: 8346588
[TBL] [Abstract][Full Text] [Related]
39. [Observations on bone mineral metabolism in natural and surgical menopause. Role of synthetic salmon calcitonin and calcium on bone turnover].
Ferrante B; Isa L; Uderzo A
Minerva Ginecol; 1993 Mar; 45(3):87-93. PubMed ID: 8332282
[TBL] [Abstract][Full Text] [Related]
40. [Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].
Kopaliani M
Georgian Med News; 2005 Apr; (121):38-42. PubMed ID: 15908722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]